Crescendo Bioscience, creators of the Vectra DA blood test to predict the progression of rheumatoid arthritis (RA), is gaining market share in the United States, with its new parent company, Myriad ...
Objectives Understanding the molecular changes in the preclinical synovium is crucial for identifying factors that drive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results